News & Events
Read our latest research news, explore upcoming events and find resources describing our mission and programs.
Latest News
NCATS Stories

NCATS Team Creates Novel Computational Pipeline to Find New Ways to Treat Glioblastoma
March 10, 2025 - NCATS News
- Analytical Chemistry
- Biomedical Data Translator (Translator)
- Informatics (IFX)
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
NCATS scientists tested a new method that could identify existing drugs effective against glioblastoma, a type of brain cancer that currently has no adequate treatments and a very low five-year survival rate.
Read Article
A Combination of Tests Shows Learning Capabilities of Nonverbal Children with Rare Brain Disorder
February 25, 2025 - NCATS News
- Our Impact on Rare Diseases
- Rare Diseases Clinical Research Network (RDCRN)
NCATS-funded scientists found that a pair of tests can measure nonverbal learning skills and show the cognitive abilities of children with Aicardi-Goutières syndrome. The tests could improve the support and therapy doctors provide.
Read ArticlePartner & Grantee News
Healthy Eating in Midlife Linked to Overall Healthy Aging
March 24, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Clinical Trial Shows Promising Results for Boosting Colorectal Cancer Screening in Rural Areas
March 17, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Full-Court Press Against Parkinson’s: Former Texas A&M Coach Billy Kennedy Finds Hope at UK
March 17, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Upcoming Events
NIH Rare Pair: Rare Disease Treatments Partnering Workshop
July 24, 2025 - July 25, 2025 - Workshop
Location: Mass General Brigham, Boston, Massachusetts
Join us for the NIH Rare Pair: Rare Disease Treatments Partnering Workshop, a pivotal event bringing together key contributors in the rare diseases ecosystem. Hosted by the National Institutes of Health (NIH), this workshop will take place July 24–25, 2025, at Mass General Brigham in Boston, Massachusetts.
This unique gathering will explore the rare diseases commercialization landscape from the diverse perspectives of industry leaders, private investors, government funders and patient advocacy organizations. Attendees will engage in dynamic panels and discussions addressing the challenges, opportunities and critical areas of interest in developing novel therapies for rare diseases.
Key highlights of the workshop include the following:
- Interactive Panels and Discussions: Gain insights into overcoming barriers and maximizing opportunities in the rare diseases treatment space.
- Rare Diseases Therapy Pitch Session: Listen to innovative NIH-supported investigators presenting cutting-edge treatments for rare diseases.
- Networking Opportunities: Build meaningful connections with researchers, investors and strategic partners driving advances in rare disease therapeutics.
Whether you’re a researcher, investor, advocate or industry professional, this workshop offers a unique opportunity to collaborate and accelerate the development of groundbreaking treatments for rare diseases.
Save the date and be part of the conversation that transforms ideas into treatments for patients with rare diseases.
Registration information and agenda will be coming soon.
Publications
Browse a listing of peer-reviewed scientific publications that feature research supported by NCATS programs and initiatives.
Matching Lines to Designs: A Novel Radiographic Index for Shorter Femoral Stems in Total Hip Arthroplasty
Clinical and Translational Science Awards (CTSA) Program - December 1, 2025 - Journal of Orthopaedics
Read PublicationOutcomes of Stretching Exercises After Lingual Frenotomy in Infants: A Prospective, Interventional Study
Clinical and Translational Science Awards (CTSA) Program - April 1, 2025 - International Journal of Pediatric Otorhinolaryngology
Read PublicationT-Cell Engagers in Multiple Myeloma: A Clinical Review
Clinical and Translational Science Awards (CTSA) Program - March 24, 2025 - Blood and Lymphatic Cancer: Targets and Therapy
Read PublicationOptimal Dietary Patterns for Healthy Aging
Clinical and Translational Science Awards (CTSA) Program - March 24, 2025 - Nature Medicine
Read PublicationEvolution of Clinical Health Information Exchanges to Population Health Resources: A Case Study of the Indiana Network for Patient Care
Clinical and Translational Science Awards (CTSA) Program - March 24, 2025 - BMC Medical Informatics and Decision Making
Read PublicationOptimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) Intervention Versus Waitlisted Group in African American Adults With Hypertension: A Randomized Control Trial Protocol
Clinical and Translational Science Awards (CTSA) Program - March 24, 2025 - Nursing: Research and Reviews
Read PublicationCOVID-19 Vaccination Uptake in Ohio: Analyzing the Difference Between Metro and Non-Metro Residents
Clinical and Translational Science Awards (CTSA) Program - March 22, 2025 - BMC Public Health
Read PublicationKey Informants’ Perceptions of Telehealth Palliative Care for People Living With Dementia in Nursing Homes
Clinical and Translational Science Awards (CTSA) Program - March 19, 2025 - BMC Geriatrics
Read PublicationPreliminary Analysis of the Impact of Lab Results on Large Language Model Generated Differential Diagnoses
Clinical and Translational Science Awards (CTSA) Program - March 18, 2025 - npj Digital Medicine
Read PublicationDeep Immunophenotyping Reveals Circulating Activated Lymphocytes in Individuals at Risk for Rheumatoid Arthritis
Clinical and Translational Science Awards (CTSA) Program - March 17, 2025 - The Journal of Clinical Investigation
Read Publication